Blucora Q3 Adj EPS $(0.20) Misses $(0.16) Estimate, Sales $171.70M Beat $165.14M Estimate

11/1/22 7:04:13 AM ET

Investment Managers

Finance

Get the next $BCOR alert in real time by email

Blucora (NASDAQ:BCOR) reported adj quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 23.08 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $171.70 million which beat the analyst consensus estimate of $165.14 million by 3.97 percent. This is a 1.42 percent decrease over sales of $174.17 million the same period last year.

Get the next $BCOR alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BCOR

Date	Price Target	Rating	Analyst
7/11/2022	$22.00	Overweight	Cantor Fitzgerald
12/14/2021	$27.00 → $22.00	Overweight → Neutral	JP Morgan

More analyst ratings

$BCOR
Press Releases

Fastest customizable press release news feed in the world

Avantax, Inc. Commences a Modified Dutch Auction Tender Offer to Repurchase up to $250 Million of its Common Stock
DALLAS, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Avantax, Inc. (NASDAQ:AVTA) (formerly known as Blucora, Inc., the "Company") announced today that it has commenced a modified "Dutch auction" tender offer (the "Tender Offer") to purchase for cash up to $250 million of its common stock, par value $0.0001 per share ("Common Stock"), at a price per share not less than $27.00 and not greater than $31.00, less any applicable withholding taxes and without interest, using proceeds from the Company's recent sale of its tax software business, which closed on December 19, 2022, and borrowings under the Company's credit facility. The Tender Offer will expire at 12:00 midnight, New York City time, at the end
1/27/23 7:56:11 AM ET
$AVTA
$BCOR
Finance: Consumer Services
Finance
Investment Managers
Avantax Announces Appointment of Tabitha Bailey as Chief Legal Officer and Corporate Secretary
DALLAS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Avantax, Inc. (NASDAQ:AVTA) (formerly known as Blucora, Inc. (NASDAQ: BCOR)), a leading provider of tax-focused wealth management services, today announced that Tabitha Bailey has been appointed Chief Legal Officer and Corporate Secretary, succeeding Ann J. Bruder, who has stepped down from her role as Chief Legal, Development and Administration Officer after nearly six years in the role. Ms. Bruder has agreed to continue to work with Avantax in a consulting role through the end of June to support the transition. "Tabitha has been a meaningful member of the Avantax team since she first joined the company, and we are very pleased to announce her ap
1/26/23 8:30:00 AM ET
$BCOR
Investment Managers
Finance
Blucora Announces New Corporate Name and Ticker Symbol
DALLAS, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of tax-focused wealth management services, today announced a corporate name change to Avantax, Inc. and a change of its NASDAQ ticker symbol from "BCOR" to "AVTA" effective as of 12:01 a.m. Eastern Time on Thursday, January 26, 2023 (the "Effective Date"). Despite this name change, the CUSIP number (095229100) remains unchanged. On the Effective Date, the Company's common stock will be quoted under the new name "Avantax, Inc.," and the Company's ticker symbol will be updated to "AVTA." No action is required by existing Blucora stockholders with respect to the name or ticker change. The Company's Chi
1/25/23 8:00:00 AM ET
$BCOR
Investment Managers
Finance

Blucora Reports Third Quarter 2022 Results
DALLAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled, tax focused financial solutions, today announced financial results for the third quarter ended September 30, 2022. Third Quarter Highlights and Recent Developments Avantax added newly recruited assets of $214 million during the third quarter for a total of approximately $1.3 billion during the first nine months of 2022. This exceeds full year 2021 newly recruited assets of $929 million.Avantax continued to deliver net positive asset flows with $380 million for the quarter and $810 million year to date.Blucora reported total revenue of $171.7 million, a decrease of 1% v
11/1/22 7:02:00 AM ET
$BCOR
Investment Managers
Finance
Blucora to Become Avantax, a Pure-Play Leading U.S. Independent Broker-Dealer and Investment Advisor That Provides Tax-Focused Wealth Management Solutions
Has Entered Into Definitive Agreement to Sell Tax Software Business for $720 Million in Cash Company to Use Proceeds to Pay Down Debt and Return Excess Capital to Shareholders Company to Streamline Operations and Rebrand as Avantax after the Closing of the TaxAct Transaction Blucora to Host Conference Call Today at 8:30 a.m. ET DALLAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. ("Blucora" or the "Company") (NASDAQ:BCOR) today announced that it has agreed to sell TaxAct, its tax software business. Under the terms of the transaction, an affiliate of Cinven will purchase TaxAct for $720 million in cash, subject to adjustment. The transaction is expected to close by the end of 2022.
11/1/22 7:00:00 AM ET
$BCOR
Investment Managers
Finance
Blucora to Announce Third Quarter 2022 Financial Results Tuesday, November 1, 2022
DALLAS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a provider of data and technology-driven tax software and wealth management solutions that empowers people to improve their financial wellness, will announce its third quarter 2022 financial results prior to market open on Tuesday, November 1, 2022. A conference call for members of the investment community will be held on Tuesday, November 1, 2022 at 8:30 a.m. ET during which the Company will discuss its third quarter 2022 results, its outlook and other business items. This call will be webcast and can be accessed within the Investor Relations section of the Blucora corporate website at www.blucora.com. About Blucora®
10/26/22 6:16:00 PM ET
$BCOR
Investment Managers
Finance

$BCOR
Leadership Updates

Live Leadership Updates

Avantax Announces Appointment of Tabitha Bailey as Chief Legal Officer and Corporate Secretary
DALLAS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Avantax, Inc. (NASDAQ:AVTA) (formerly known as Blucora, Inc. (NASDAQ: BCOR)), a leading provider of tax-focused wealth management services, today announced that Tabitha Bailey has been appointed Chief Legal Officer and Corporate Secretary, succeeding Ann J. Bruder, who has stepped down from her role as Chief Legal, Development and Administration Officer after nearly six years in the role. Ms. Bruder has agreed to continue to work with Avantax in a consulting role through the end of June to support the transition. "Tabitha has been a meaningful member of the Avantax team since she first joined the company, and we are very pleased to announce her ap
1/26/23 8:30:00 AM ET
$BCOR
Investment Managers
Finance
Blucora Announces Appointment of Kan Kotecha and Rick Leaman to the Board of Directors
DALLAS, March 11, 2022 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled, tax-focused financial solutions, today announced the appointment of Kan Kotecha and Rick Leaman to the Company's Board of Directors, effective immediately. The appointments complete a search process initiated in 2021 by the Blucora Board of Directors, which was conducted with the input of Blucora's shareholders and the assistance of a leading executive search firm. Mr. Kotecha is currently a Vice President of Engineering at Google Inc. and previously served as Chief Technology Officer at Morgan Stanley Wealth Management where he led a team of over 600 professionals. He bring
3/11/22 1:45:00 PM ET
$BCOR
Investment Managers
Finance
Blucora Announces First Quarter 2021 Results
DALLAS, May 05, 2021 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled, tax focused financial solutions, today announced financial results for the first quarter ended March 31, 2021. First Quarter Highlights and Recent Developments Increased total revenue for the quarter to $278.4 million, or 6% year-over-yearGAAP Net Income of $27.6 million, or $0.56 per diluted shareNon-GAAP Net Income of $51.0 million, or $1.04 per diluted shareTotal client assets ended the quarter up 39% year over year to $84.8 billion, with $36.8 billion, or 43.4% in advisory assetsAdvisory assets increased 56% year-over-year, including the addition of approximately $5.0 billi
5/5/21 6:30:00 AM ET
$BCOR
Investment Managers
Finance

$BCOR
Market Insights

Live Market Insights

Blucora's Return on Invested Capital Insights
Benzinga Pro data, Blucora (NASDAQ:BCOR) reported Q3 sales of $171.70 million. Earnings fell to a loss of $21.84 million, resulting in a 155.4% decrease from last quarter. Blucora earned $39.42 million, and sales totaled $256.88 million in Q2. Why Is ROIC Significant? Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company's ROIC. A higher ROIC is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROIC suggests the opposite. In Q3, Blucora posted an ROIC of 4.66%. Keep in mind, while ROIC is a good
11/7/22 9:20:04 AM ET
$BCOR
Investment Managers
Finance
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers Abiomed, Inc. (NASDAQ:ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company . Also, the company reported better-than-expected Q2 adjusted EPS results. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) gained 46.6% to close at $2.83. Sonnet BioTherapeutics recently announced an agreement with Janssen for the evaluation of three Sonnet product candidates. NLS Pharmaceutics AG (NASDAQ:NLSP) gained 44% to settle at $0.74. NLS Pharmaceutics was granted FDA Orpha Drug Designation for Quilience (Mazindol) for the treatment of idiopathic hypersomnia. Ucommune International Ltd (NASDAQ:UK) jumped 34.7% to close at $1.
11/2/22 5:07:52 AM ET
$ABMD
$ACOR
$AGLE
$AMBO
Medical/Dental Instruments
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Gartner, Sony, Uber And Other Big Gainers From Tuesday
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. Abiomed, Inc. (NASDAQ:ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company. Also, the company reported better-than-expected Q2 adjusted EPS results. Harsco Corporation (NYSE:HSC) climbed 22.5% to close at $6.48 after the company reported better-than-expected Q3 sales results and raised FY22 adjusted EPS guidance. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) rose 14% to settle at $59.26 after the company reported better-than-expected Q3 EPS and sales r
11/2/22 2:57:49 AM ET
$ABMD
$ATHM
$BCOR
$BZ
Medical/Dental Instruments
Health Care
EDP Services
Technology

Blucora Q3 Adj EPS $(0.20) Misses $(0.16) Estimate, Sales $171.70M Beat $165.14M Estimate

Chat with this insight

Recent Analyst Ratings for $BCOR

$BCOR Press Releases

Fastest customizable press release news feed in the world

Avantax, Inc. Commences a Modified Dutch Auction Tender Offer to Repurchase up to $250 Million of its Common Stock

Avantax Announces Appointment of Tabitha Bailey as Chief Legal Officer and Corporate Secretary

Blucora Announces New Corporate Name and Ticker Symbol

$BCOR Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Cantor Fitzgerald initiated coverage on Blucora with a new price target

Blucora downgraded by JP Morgan with a new price target

The Benchmark Company reiterated coverage on Blucora with a new price target

$BCOR Financials

Live finance-specific insights

$BCOR Large Ownership Changes

This live feed shows all institutional transactions in real time.

$BCOR SEC Filings

Blucora Reports Third Quarter 2022 Results

Blucora to Become Avantax, a Pure-Play Leading U.S. Independent Broker-Dealer and Investment Advisor That Provides Tax-Focused Wealth Management Solutions

Blucora to Announce Third Quarter 2022 Financial Results Tuesday, November 1, 2022

SEC Form SC 13G filed by Blucora Inc.

SEC Form SC 13G/A filed by Blucora Inc. (Amendment)

SEC Form SC 13G/A filed by Blucora Inc. (Amendment)

SEC Form 15-12G filed by Blucora Inc.

SEC Form EFFECT filed by Blucora Inc.

SEC Form EFFECT filed by Blucora Inc.

$BCOR Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Mehlman Marc returned $4,448,860 worth of shares to the company (171,110 units at $26.00) and was granted 80,718 shares, closing all direct ownership in the company (SEC Form 4)

Walters Christopher William returned $22,551,854 worth of shares to the company (867,379 units at $26.00) and was granted 513,258 shares, closing all direct ownership in the company (SEC Form 4)

Murray Stacy returned $73,996 worth of shares to the company (2,846 units at $26.00), closing all direct ownership in the company (SEC Form 4)

$BCOR Leadership Updates

Live Leadership Updates

Avantax Announces Appointment of Tabitha Bailey as Chief Legal Officer and Corporate Secretary

Blucora Announces Appointment of Kan Kotecha and Rick Leaman to the Board of Directors

Blucora Announces First Quarter 2021 Results

$BCOR Market Insights

Live Market Insights

Blucora's Return on Invested Capital Insights

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday

Gartner, Sony, Uber And Other Big Gainers From Tuesday

Recent Analyst Ratings for
$BCOR

$BCOR
Press Releases

$BCOR
Analyst Ratings

$BCOR
Financials

$BCOR
Large Ownership Changes

$BCOR
SEC Filings

$BCOR
Insider Trading

$BCOR
Leadership Updates

$BCOR
Market Insights